IONS Earnings

Quarterly EPS
$-0.95
Q3 2024
$-0.66
Q4 2024
$-0.93
Q1 2025
$0.78
Q2 2025
$-0.80
Q3 2025
$-1.41
Q4 2025
$-0.56
Q1 2026
$-0.69
Q2 2026
Latest Revenue267.9M
Latest Net Income-114646000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.69267.9M-114646000-40.7%-188.5%
Q1 2026-$0.56246.1M-92528000+87.0%+39.8%
Q4 2025-$1.41203.3M-229394000-10.3%-113.6%
Q3 2025-$0.80156.7M-128606000+17.1%+15.8%
Q2 2025$0.78452.0M123.6M+100.7%+273.3%
Q1 2025-$0.93131.6M-146938000+10.1%+5.1%
Q4 2024-$0.66226.6M-104349000-30.2%-1,000.0%
Q3 2024-$0.95133.8M-140480000-7.2%+7.8%
Q2 2024-$0.45225.3M-66265000
Q1 2024-$0.98119.5M-142803000
Q4 2023-$0.06324.5M-9263000
Q3 2023-$1.03144.2M-147410000
Ionis Pharmaceuticals (IONS) — Earnings